Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion type Assertion NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_head.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion description "[Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_provenance.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion evidence source_evidence_literature NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_provenance.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion SIO_000772 18829562 NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_provenance.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion wasDerivedFrom befree-20140225 NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_provenance.
- NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_assertion wasGeneratedBy ECO_0000203 NP316475.RAx1ho45vjgKh2DEcwdIneMRu26gBu0oJ5yFVQXmgmk1Q130_provenance.